Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder

NCT04730011 | Recruiting

• 1 other identifier: KJPP 2020-02053
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Obsessive-compulsive disorders are very damaging illnesses; they can already appear in childhood and adolescence and become extremely chronic. With an average prevalence from 1-3%, they are among the most common psychiatric disorders in children and adolescents. 40% of diagnosed children and young adults display persistent and increasingly chronic symptoms and O-C disorders are highly complex syndromes with broadly varying manifestations. They arise from obsessive thoughts (ideas/thoughts or impulses, often senseless or tortured, that impose themselves or intrude) and obsessive behavior (ritualized patterns that must be frequently repeated).

Conditions

Obsessive-Compulsive Disorder

Outcome Measures

Primary Outcomes (1)

• Symptoms severity of obsessive and compulsive symptoms in children and adolescents

  The clinician-report questionnaire (BY-BOCS) contains 19 items designed to assess severity of obsessive and compulsive symptoms in children and adolescents.The test uses a 4-point scale to rate the severity of their obsessive compulsive behaviors. Higher score means a worse outcome.

  12 months

Study Arms (1)

Treatment Group

EXPERIMENTAL

Patients are treated based on the Cognitive Behavioral Psychotherapy. This includes individual and group sessions over one week.

Behavioral: Short and Intensive Treatment

Interventions

Short and Intensive Treatment BEHAVIORAL

Intensive Treatment Week with behavioural psychotherapy

Treatment Group

Eligibility Criteria

• Age: 8 Years - 18 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Obsessive-Compulsive Disorder diagnosis
• Male and female patients from 8-18 years
• Good German language speaking skills
• IQ of at least 75
• At least four days' participation in the treatment/therapy week
• Written agreement after clear explanation

You may not qualify if:

• \- No complete participation in the intensive week treatment/therapy

Sponsors & Collaborators

• Susanne Walitza: lead

Study Sites (1)

Psychiatric University Clinics, Department of Child and Adolescent Psychiatry

Zurich, Canton of Zurich, 8032, Switzerland

RECRUITING

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Anxiety Disorders; Mental Disorders

Study Officials

• Susanne Walitza, Prof. Dr. med. Dipl.-Psych.

  Sponsor GmbH

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Susanne Walitza, Prof. Dr. med. Dipl.-Psych.

CONTACT

+41 (0)43 499 26 26; susanne.walitza@puk.zh.ch

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Head of the Department of Child and Adolescent Psychiatry

Study Record Dates

• First Submitted: January 25, 2021
• First Posted: January 29, 2021
• Study Start: January 1, 2021
• Primary Completion (Estimated): December 31, 2028
• Study Completion (Estimated): December 31, 2028
• Last Updated: May 13, 2025

Record last verified: 2025-05

Data Sharing

• IPD Sharing: Will not share

Locations

CH (1)